Strengthening the role of the IBC in the 21st century Introduction 217 IBC review of DURC 221 US government (USG) policy and guidelines on DURC 221 DURC 222 A case study: IBC review of the Fouchier and Kawaoka studies that triggered the 2011 influenza A/H5N1 gain-of-function controversy 225 Risk and benefit analyses of gain-of-function studies with influenza A/H5N1 virus 227 Options for an additional level of review for DURC The increasing burden of regulatory review 234 Regulatory compliance for research institutions: an unfunded mandate 236